BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 19411248)

  • 1. Low pH-dependent hepatitis C virus membrane fusion depends on E2 integrity, target lipid composition, and density of virus particles.
    Haid S; Pietschmann T; Pécheur EI
    J Biol Chem; 2009 Jun; 284(26):17657-67. PubMed ID: 19411248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanism.
    Douam F; Fusil F; Enguehard M; Dib L; Nadalin F; Schwaller L; Hrebikova G; Mancip J; Mailly L; Montserret R; Ding Q; Maisse C; Carlot E; Xu K; Verhoeyen E; Baumert TF; Ploss A; Carbone A; Cosset FL; Lavillette D
    PLoS Pathog; 2018 Mar; 14(3):e1006908. PubMed ID: 29505618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes.
    Lavillette D; Bartosch B; Nourrisson D; Verney G; Cosset FL; Penin F; Pécheur EI
    J Biol Chem; 2006 Feb; 281(7):3909-17. PubMed ID: 16356932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological and biochemical characterization of the membranous hepatitis C virus replication compartment.
    Paul D; Hoppe S; Saher G; Krijnse-Locker J; Bartenschlager R
    J Virol; 2013 Oct; 87(19):10612-27. PubMed ID: 23885072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection.
    Bocchetta S; Maillard P; Yamamoto M; Gondeau C; Douam F; Lebreton S; Lagaye S; Pol S; Helle F; Plengpanich W; Guérin M; Bourgine M; Michel ML; Lavillette D; Roingeard P; le Goff W; Budkowska A
    PLoS One; 2014; 9(3):e92140. PubMed ID: 24646941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles.
    Tao W; Xu C; Ding Q; Li R; Xiang Y; Chung J; Zhong J
    Virology; 2009 Dec; 395(1):67-76. PubMed ID: 19793603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry.
    Triyatni M; Saunier B; Maruvada P; Davis AR; Ulianich L; Heller T; Patel A; Kohn LD; Liang TJ
    J Virol; 2002 Sep; 76(18):9335-44. PubMed ID: 12186916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Analysis of Hepatitis C Virus (HCV) Envelope Protein E1 Using a
    Tong Y; Chi X; Yang W; Zhong J
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28100619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane Fusion Assays for Studying Entry Hepatitis C Virus into Cells.
    Denolly S; Cosset FL; Freitas N
    Methods Mol Biol; 2019; 1911():219-234. PubMed ID: 30593629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A serum protein factor mediates maturation and apoB-association of HCV particles in the extracellular milieu.
    Denolly S; Granier C; Fontaine N; Pozzetto B; Bourlet T; Guérin M; Cosset FL
    J Hepatol; 2019 Apr; 70(4):626-638. PubMed ID: 30553840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatiotemporal Coupling of the Hepatitis C Virus Replication Cycle by Creating a Lipid Droplet- Proximal Membranous Replication Compartment.
    Lee JY; Cortese M; Haselmann U; Tabata K; Romero-Brey I; Funaya C; Schieber NL; Qiang Y; Bartenschlager M; Kallis S; Ritter C; Rohr K; Schwab Y; Ruggieri A; Bartenschlager R
    Cell Rep; 2019 Jun; 27(12):3602-3617.e5. PubMed ID: 31216478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusogenic properties of the Ectodomain of HCV E2 envelope protein.
    Rodríguez-Rodríguez M; Tello D; Gómez-Gutiérrez J; Peterson DL; Gavilanes F; Yélamos B
    Biochim Biophys Acta Biomembr; 2018 Mar; 1860(3):728-736. PubMed ID: 29273334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of HCV entry into host cells.
    Douam F; Lavillette D; Cosset FL
    Prog Mol Biol Transl Sci; 2015; 129():63-107. PubMed ID: 25595801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
    Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
    J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SR-BI partner PDZK1 facilitates hepatitis C virus entry.
    Eyre NS; Drummer HE; Beard MR
    PLoS Pathog; 2010 Oct; 6(10):e1001130. PubMed ID: 20949066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse hepatic cells support assembly of infectious hepatitis C virus particles.
    Long G; Hiet MS; Windisch MP; Lee JY; Lohmann V; Bartenschlager R
    Gastroenterology; 2011 Sep; 141(3):1057-66. PubMed ID: 21699799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipids: a key for hepatitis C virus entry and a potential target for antiviral strategies.
    Blaising J; Pécheur EI
    Biochimie; 2013 Jan; 95(1):96-102. PubMed ID: 22884392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syntenin regulates hepatitis C virus sensitivity to neutralizing antibody by promoting E2 secretion through exosomes.
    Deng L; Jiang W; Wang X; Merz A; Hiet MS; Chen Y; Pan X; Jiu Y; Yang Y; Yu B; He Y; Tu Z; Niu J; Bartenschlager R; Long G
    J Hepatol; 2019 Jul; 71(1):52-61. PubMed ID: 30880226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HCV 3a genotype entry through host CD81 and HCV E2 antibodies.
    Ashfaq UA; Qasim M; Yousaf MZ; Awan MT; Jahan S
    J Transl Med; 2011 Nov; 9():194. PubMed ID: 22074322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular proton conductance of the hepatitis C virus p7 protein and its contribution to infectious virus production.
    Wozniak AL; Griffin S; Rowlands D; Harris M; Yi M; Lemon SM; Weinman SA
    PLoS Pathog; 2010 Sep; 6(9):e1001087. PubMed ID: 20824094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.